IGF1R作为抗糖尿病药物中介性勃起功能障碍预防的保护性标:从遗传学的洞察
Yuqi Li1, Juan Wang1, Tao Zhou1
1Department of Urology, Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646000, China.
抗糖尿病药物标可能会影响勃起功能障碍 (ED) 风险. 这项研究发现,胰岛素样生长因子1受体 (IGF1R) 可能会防止ED,这表明潜在的治疗益处.
科学领域:
- 药物基因组学 药物基因组学
- 内分泌学 在内分泌学.
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
背景情况:
- 抗糖尿病药物越来越多地被用于非糖尿病疾病.
- 抗糖尿病药物标对勃起功能障碍 (ED) 的影响尚不清楚.
- 这项研究调查了抗糖尿病药物标和ED风险之间的遗传联系.
研究的目的:
- 探索抗糖尿病药物标基因与ED之间的因果关系.
- 通过药物重新利用来确定ED治疗的潜在目标.
- 为在ED治疗中使用抗糖尿病药物提供理论支持.
主要方法:
- 使用了门德尔的随机化 (MR) 分析.
- 确定了八种抗糖尿病药物类别的向基因.
- 用MR,元分析和SMR来评估关联,并进行敏感性分析.
主要成果:
- 研究了24种与ED相关的抗糖尿病药物向基因.
- 确定了11个重要的目标基因.
- 发现胰岛素样生长因子1受体 (IGF1R) 和ED (OR 0.907,P < 0.001) 之间存在显著的负相关性.
结论:
- 增加IGF1R表达与ED风险降低有关.
- 这表明IGF1R可能对ED有保护作用.
- 合理使用胰岛素和类似物可能为ED提供预防性益处.
更多相关视频
12:21Fabrication and Characterization of Griffithsin-modified Fiber Scaffolds for Prevention of Sexually Transmitted Infections
Published on: October 31, 2017
09:49Isolation of Adipose Derived Regenerative Cells for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Published on: December 28, 2021
相关概念视频
Dipeptidyl Peptidase 4 Inhibitors
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Antihypertensive Drugs: Direct Renin Inhibitors
